Literature DB >> 11440728

Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography--tandem mass-spectrometry.

A Volosov1, K L Napoli, S J Soldin.   

Abstract

OBJECTIVES: The aim of the current study was to develop a simple, fast and universal method for quantification of any combination of the three major immunosuppressants sirolimus, tacrolimus and cyclosporin in whole blood, using a LC-tandem mass spectrometer (API-2000, SCIEX, Toronto, Canada).
METHODS: 250 microL whole blood was spiked with internal standard (ritonavir), and protein precipitated with 350 microL acetonitrile. The sample was centrifuged and 30 microL aliquot was injected onto the HPLC column, where it underwent an online extraction with ammonium acetate. After that the automatic switching valve was activated, changing the mobile phase to methanol and thereby eluting the analytes into the tandem mass spectrometer. The high selectivity of a tandem mass analyzer allows determination of any combination of the three drugs within a 5 min run.
RESULTS: Between-day precision was between 2.4% and 9.7% for all analytes at the concentrations tested. Accuracy ranged between 98.8% and 103.2% (n = 20). The method was linear over the measuring ranges of all analytes. Within-run precision was below %CV = 6% for all analytes. Good correlation with other analytical methods was observed.
CONCLUSIONS: The simplicity, universality and high throughput of the method make it suitable for application in a clinical laboratory. The method has been implemented in our laboratory for a routine use.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440728     DOI: 10.1016/s0009-9120(01)00235-1

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  12 in total

1.  Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients.

Authors:  Violette Gijsen; Seema Mital; Ron H van Schaik; Offie P Soldin; Steven J Soldin; Ilse P van der Heiden; Irena Nulman; Gideon Koren; Saskia N de Wildt
Journal:  J Heart Lung Transplant       Date:  2011-09-17       Impact factor: 10.247

Review 2.  Therapeutic drug monitoring in human immunodeficiency virus/acquired immunodeficiency syndrome. Quo vadis?

Authors:  Offie Porat Soldin; Ronald J Elin; Steven J Soldin
Journal:  Arch Pathol Lab Med       Date:  2003-01       Impact factor: 5.534

3.  Donor CYP3A5 genotype influences tacrolimus disposition on the first day after paediatric liver transplantation.

Authors:  Pier Luigi Calvo; Loredana Serpe; Andrea Brunati; Antonello Nonnato; Daniela Bongioanni; Dominic Dell' Olio; Michele Pinon; Carlo Ferretti; Francesco Tandoi; Giulia Carbonaro; Mauro Salizzoni; Antonio Amoroso; Renato Romagnoli; Roberto Canaparo
Journal:  Br J Clin Pharmacol       Date:  2017-01-31       Impact factor: 4.335

4.  Hyperglycemia induced by tacrolimus and sirolimus is reversible in normal sprague-dawley rats.

Authors:  Vijay Shivaswamy; Marissa McClure; Joel Passer; Christin Frahm; LuAnn Ochsner; Judi Erickson; Robert G Bennett; Frederick G Hamel; Jennifer L Larsen
Journal:  Endocrine       Date:  2010-04-13       Impact factor: 3.633

5.  Tacrolimus and sirolimus induce reproductive abnormalities in female rats.

Authors:  Vijay Shivaswamy; Luann Ochsner; Dulce Maroni; Cheng Wang; Joel Passer; Cara E Clure; Frederick G Hamel; John S Davis; Jennifer Larsen
Journal:  Transplantation       Date:  2011-06-27       Impact factor: 4.939

Review 6.  Sirolimus: the evidence for clinical pharmacokinetic monitoring.

Authors:  Sunita Bond Stenton; Nilufar Partovi; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 7.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Milk transfer and neonatal safety of tacrolimus.

Authors:  Amy E French; Steven J Soldin; Offie P Soldin; Gideon Koren
Journal:  Ann Pharmacother       Date:  2003-06       Impact factor: 3.154

9.  Dyslipidemia can be controlled in diabetic as well as nondiabetic recipients after kidney transplant.

Authors:  Vijay Shivaswamy; R Brian Stevens; Ramona Zephier; Myhra Zephier; Junfeng Sun; Gerald Groggel; Judi Erickson; Jennifer Larsen
Journal:  Transplantation       Date:  2008-05-15       Impact factor: 4.939

10.  A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples.

Authors:  Christoph Seger; Karin Tentschert; Wolfgang Stöggl; Andrea Griesmacher; Steven L Ramsay
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.